Kirsty (Insulin Aspart)

Insulin Aspart, the active ingredient in Kirsty, is a rapid‑acting insulin analog presented as an injectable solution for subcutaneous use. It is used to improve glycaemic control in people with diabetes mellitus, including both type 1 and type 2 forms. GNH USA supplies Kirsty as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulin Aspart is a rapid‑acting insulin analog that lowers blood glucose by facilitating cellular uptake. It is indicated for the following conditions: - Type 1 diabetes mellitus: provides mealtime glucose control and reduces post‑prandial spikes. - Type 2 diabetes mellitus: used when oral agents are insufficient to achieve target glycaemia. - Gestational diabetes mellitus: helps maintain maternal glucose levels within recommended ranges during pregnancy.

Insulin Aspart may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Hypoglycaemia: low blood sugar episodes, especially if meals are missed. - Injection site reactions: redness, swelling, or itching at the injection site. - Lipodystrophy: localized changes in subcutaneous fat with repeated injections. - Nausea or abdominal discomfort. - Weight gain: due to improved glucose utilization.

Serious or Rare Side Effects: - Severe hypoglycaemia leading to seizures or loss of consciousness. - Allergic reactions: rash, urticaria, or anaphylaxis. - Hypokalemia: low potassium levels. - Edema: fluid retention, particularly in the lower extremities. - Hypoglycaemia unawareness: diminished ability to recognize low glucose symptoms.

When using Insulin Aspart, several safety considerations are important. - Blood glucose monitoring: check levels frequently to adjust dose as needed. - Dose adjustments: modify insulin when dietary intake, activity, or illness changes. - Hypoglycaemia unawareness: avoid in patients who cannot recognize low glucose symptoms. - Renal or hepatic impairment: use with caution and consider dose reduction. - Pregnancy and lactation: safety category unknown; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin Aspart can interact with other medicines, affecting glucose control.

Major Interactions (Avoid): - Sulfonylureas: additive risk of severe hypoglycaemia. - Beta‑blockers: may mask hypoglycaemia symptoms. - Glucocorticoids: can increase blood glucose, reducing insulin effectiveness.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors: may potentiate insulin’s glucose‑lowering effect. - Thiazide diuretics: can raise blood glucose levels. - Alcohol: may cause unpredictable hypoglycaemia, especially with missed meals.